Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 101 peer-reviewed journal articles Updated
Hepatology

Primary Sclerosing Cholangitis (PSC): A Patient Guide

At a Glance

Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease that causes inflammation and scarring in the bile ducts. While there is no medical cure and some patients may eventually need a liver transplant, progression varies widely, and many manage the disease for decades.

You have just been diagnosed with Primary Sclerosing Cholangitis (PSC). It is completely normal to feel shocked, scared, and overwhelmed. PSC is a rare disease, and you may find that even many healthcare professionals have never treated a case. This guide is designed to give you the information you need to understand your diagnosis, ask the right questions, and advocate for the best possible care.

What is PSC?

Primary Sclerosing Cholangitis is a chronic, rare liver disease where the bile ducts (the tubes that carry digestive fluid from the liver to the intestines) become inflamed and scarred [1]. Over time, this scarring can block the flow of bile, causing it to build up in the liver and eventually lead to liver damage.

There is currently no medical cure that halts or reverses the disease, and for many, a liver transplant is the ultimate life-extending treatment [2][3]. However, the disease progresses very differently from person to person. Many people live for decades with the condition before needing a transplant, and some never require one at all.

How to Use This Guide

This guide is broken down into specific topics to help you navigate your journey with PSC. You do not need to read it all at once; use it as a reference as you move through your care.

01

What is PSC? Biology & Look-Alike Conditions

Learn about Primary Sclerosing Cholangitis (PSC) biology and how it is diagnosed. Understand MRCP imaging, onion-skin fibrosis, and look-alike conditions.

02

PSC Subtypes and the IBD Connection

Learn about Primary Sclerosing Cholangitis (PSC) subtypes like large and small-duct PSC, and understand the critical link between PSC, IBD, and colon health.

03

Managing PSC Symptoms: Itching and Fatigue

Learn how to manage severe itching (pruritus) and profound fatigue caused by Primary Sclerosing Cholangitis (PSC). Explore step-by-step treatment options.

04

Treatments, Procedures, and Liver Transplant

Explore treatment options for Primary Sclerosing Cholangitis (PSC). Learn about UDCA medication, ERCP for bile duct blockages, and liver transplantation.

05

Surveillance and Cancer Risks in PSC

Understand cancer risks associated with Primary Sclerosing Cholangitis (PSC) and learn the recommended surveillance schedule for MRCP, CA 19-9, and colonoscopy.

06

Understanding Prognosis and Risk Scores

Learn how to interpret your Primary Sclerosing Cholangitis (PSC) risk scores. Understand the Revised Mayo score, UK-PSC, PREsTo, and FibroScan results.

This guide will not give you medical advice, but it will empower you with the facts so you can work with your medical team as an informed partner.

Common questions in this guide

What is Primary Sclerosing Cholangitis (PSC)?
PSC is a rare, chronic liver disease where the bile ducts become inflamed and scarred. This scarring blocks the normal flow of bile, causing it to build up and potentially damage the liver over time.
Is there a cure for PSC?
There is currently no medical cure that halts or reverses PSC. For many patients, a liver transplant is the ultimate life-extending treatment, though disease progression varies greatly from person to person, and some never require a transplant.
How is PSC connected to Inflammatory Bowel Disease (IBD)?
There is a very strong link between PSC and Inflammatory Bowel Disease (IBD), such as Ulcerative Colitis. Because of this connection, doctors typically recommend an immediate colonoscopy for newly diagnosed PSC patients.
What kind of doctor should treat PSC?
Because PSC is a rare condition, it is best managed by a specialist with specific experience in liver diseases. Patients should ideally work with a hepatologist who is connected to a transplant center.
What should I do if I get a sudden fever or abdominal pain?
Sudden changes like a fever or severe abdominal pain can be signs of a serious complication, such as a blocked or infected bile duct. You should contact your hepatologist or seek medical care immediately based on the communication plan you established with your doctor.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with PSC do you currently treat in your practice?
  2. 2.Are you connected with a hepatologist at a transplant center who can consult on my case if needed?
  3. 3.What is the best way for us to communicate if I experience a sudden change in my symptoms, such as a fever or severe abdominal pain?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (3)
  1. 1

    Endoscopic management of primary sclerosing cholangitis.

    Mizuno S, Uchida Y, Ando S, et al.

    Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 2025; (37(7)):723-732 doi:10.1111/den.15010.

    PMID: 40049717
  2. 2

    Primary sclerosing cholangitis: A review and update.

    Tabibian JH, Bowlus CL

    Liver research (Beijing, China) 2017; (1(4)):221-230 doi:10.1016/j.livres.2017.12.002.

    PMID: 29977644
  3. 3

    Primary sclerosing cholangitis.

    Rabiee A, Silveira MG

    Translational gastroenterology and hepatology 2021; (6()):29 doi:10.21037/tgh-20-266.

    PMID: 33824933

This guide is for informational purposes only and does not replace professional medical advice. Always consult with your hepatologist or gastroenterologist regarding your specific PSC diagnosis and treatment plan.

Get notified when new evidence is published on Primary sclerosing cholangitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.